V-01

Last updated

V-01
Vaccine description
Target SARS-CoV-2
Vaccine type Protein subunit
Clinical data
Routes of
administration
Intramuscular

V-01 is a COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group Inc. [1] [2] [3]

Related Research Articles

<i>Hanyu Shuiping Kaoshi</i> Test of Standard Chinese proficiency for non-native Chinese speakers

The Hanyu Shuiping Kaoshi, translated as the Chinese Proficiency Test, is the standardized test of Standard Chinese language proficiency of China for non-native speakers such as foreign students and overseas Chinese. The test is administered by the Hanban, an agency of the Ministry of Education of the People's Republic of China.

Ankang is a name shared by a number of psychiatric hospitals or asylums in China. The term literally means "peace and health [for the mentally ill]". Many of these institutions are prison-hospitals for holding prisoners judged to be mentally ill, and operate directly under the local Public Security Bureau. As a result, "ankang" is sometimes used in the Western press to denote the system of prison-hospitals in China. However, not all ankang hospitals are prison-hospitals, and some offer conventional psychiatric and medical treatment services.

Zhang Zhaohuan

Zhang, Zhaohuan (张照寰) was born in Zhenjiang, China, in 1925. He graduated from the Faculty of Medicine, Shanghai Medical College in 1950. Because of his outstanding school performance and academic potential, he was offered a lectureship by his alma mater upon graduation—a practice that is still in vogue in almost all universities in China when recruiting exceptional faculty members is difficult. In the eight years that followed, he worked there first as a lecturer and then an associate professor and associate director.

Deng Jiajia is a Chinese actress.

Differences between Shinjitai and Simplified characters

Differences between Shinjitai and Simplified characters in the Japanese and Chinese languages exist.

SESH is a partnership between Southern Medical University Dermatology Hospital and the University of North Carolina Project-China that uses crowdsourcing to improve health. In China, the team lead the “Sex + Health” image crowdsourcing contest, a condom contest, crowdsourcing for patterns for HIV testing and referrals, and the "HepTestContest,” a global hepatitis testing contest. Together with the World Health Organization, SESH helped develop the HepTestContest. The purpose was to identify and evaluate Hepatitis B/C testing projects throughout the world. They also organized the "Healthy Cities Contest" and helped to advise on "2BeatHIV."

COVID-19 pandemic in mainland China Ongoing COVID-19 viral pandemic in mainland China

The COVID-19 pandemic in mainland China is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). China was the first country to identify the disease and its pathogen, the first country to impose drastic measures in response to the outbreak, and one of the first countries to bring the outbreak under control. The outbreak was first manifested as a cluster of mysterious pneumonia cases, mostly related to the Huanan Seafood Market, in Wuhan, the capital of Hubei province. The outbreak was first reported to the local government on 27 December 2019 and published on 31 December. On 8 January 2020, a new coronavirus (SARS-CoV-2) was identified as the cause of the pneumonia by Chinese scientists.

The COVID-19 pandemic in Hubei was first manifested by a cluster of mysterious pneumonia in Wuhan, the provincial capital of Hubei, China. A Wuhan hospital notified the local center for disease control and prevention (CDC) and health commissions on December 27, 2019. On December 31, Wuhan CDC admitted that there was a cluster of unknown pneumonia cases related to Huanan Seafood Wholesale Market after the unverified documents appeared on the Internet. The potential disease outbreak soon drew nationwide attention including that of the National Health Commission (NHC) in Beijing which sent experts to Wuhan on the following day. On January 8, a new coronavirus was identified as the cause of the pneumonia. The sequence of the virus was soon published on an open-access database. Measures taken by China have been controversial. They were praised by the World Health Organization (WHO) for improvements over SARS-CoV-2 responses, but maligned by many in the international community for being slow to publicly disclose key facts or deceptive about the outbreak and for aggressively censoring information relating to the outbreak and public discontent from citizens online.

COVID-19 pandemic in Shanghai Ongoing COVID-19 viral pandemic in Shanghai

The COVID-19 pandemic reached the city of Shanghai on 20 January 2020. As of 14 November 2020, 1,277 confirmed cases cumulatively occurred in the city, of which 934 cases were imported from abroad. Of the 96 active hospitalized cases ending at midnight, 94 were in stable condition and 1 was in critical condition; 1,174 had cumulatively recovered and been discharged, and 7 died.

The COVID-19 pandemic reached the province of Sichuan, People's Republic of China on 20 January 2020, with its first case confirmed on the next day.

Zhang Wenhong Chinese doctor

Zhang Wenhong is a Chinese doctor, and a member of the Communist Party of China. He is the Director and Secretary of the Party Branch of the Department of Infectious Diseases at Huashan Hospital affiliated to Fudan University, the Director of the Internal Medicine Department of the Shanghai Medical College, and also the leader of the Shanghai Medical Treatment Experts Group, deputy director of the Shanghai Institute of Liver Diseases, and standing committee member of the Infectious Disease Branch of the Chinese Medical Association.

This article documents the situation of the COVID-19 pandemic in Inner Mongolia, the People's Republic of China.

The COVID-19 epidemic in Xinjiang Uyghur Autonomous Region is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On 23 January 2020, the local government confirmed the first two case in Urumchi, the capital city of Xinjiang.

Responses to the COVID-19 pandemic in February 2020 Sequence of major events in a virus pandemic

This article documents the chronology of the response to the COVID-19 pandemic in February 2020, which originated in Wuhan, China in December 2019. Some developments may become known or fully understood only in retrospect. Reporting on this outbreak began in December 2019.

COVID-19 pandemic in Beijing COVID-19 viral pandemic in Beijing, China

The COVID-19 pandemic reached the municipality of Beijing, China on 20 January 2020.

This article presents official statistics gathered during the COVID-19 pandemic in mainland China.

COVID-19 vaccination in Japan

COVID-19 vaccination in Japan started later than in most other major economies.

COVID-19 vaccination in mainland China Plan to immunize against COVID-19

COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.

References

  1. "China approves clinical trials for Livzon Pharma unit's COVID-19 vaccine". Reuters. 23 March 2021. Retrieved 21 April 2021.
  2. "评价重组新型冠状病毒融合蛋白疫苗在健康人群免疫原性和安全性随机、双盲、安慰剂对照的II期临床试验". chictr.org.cn. Chinese Clinical Trial Registry. Retrieved 21 April 2021.
  3. "评价重组新型冠状病毒融合蛋白疫苗在健康人群安全性和免疫原性随机、双盲、安慰剂对照的I期临床试验". chictr.org.cn. Chinese Clinical Trial Registry. Retrieved 21 April 2021.